Table 4.
Comparison of patient data between the good and impaired quality of life groups
| Consideration | Good quality of life group (n = 35) | Poor quality of life group (n = 41) | χ2/t value | P-value |
|---|---|---|---|---|
| Age | 64.00 [62.00, 66.00] | 67.00 [63.00, 70.00] | -2.36 | 0.018 |
| Gender | ||||
| Male | 18 | 21 | 0.000 | 0.985 |
| Female | 17 | 20 | ||
| Course of disease | 5.93±1.90 | 5.43±1.84 | 1.160 | 0.250 |
| NYHA | ||||
| II | 18 | 14 | 2.313 | 0.128 |
| III | 17 | 27 | ||
| Monthly household income (yuan) | ||||
| ≥3000 | 14 | 12 | 0.966 | 0.326 |
| <3000 | 21 | 29 | ||
| History of diabetes | ||||
| Yes | 5 | 13 | 3.171 | 0.075 |
| No | 30 | 28 | ||
| Smoking history | ||||
| Yes | 14 | 21 | 0.957 | 0.328 |
| No | 21 | 20 | ||
| Treatment plan | ||||
| Control subjects | 14 | 24 | 2.595 | 0.107 |
| CGU | 21 | 17 | ||
| Pre-intervention Chinese medicine evidence score | 16.05±3.57 | 17.00±4.72 | -0.977 | 0.332 |
| Pre-intervention 6 min walking distance (m) | 229.98±14.26 | 232.89±12.81 | -0.937 | 0.352 |
| Pre-intervention LVEDD (mm) | 43.56±4.64 | 45.37±4.52 | -1.719 | 0.090 |
| Pre-intervention LVEF (%) | 38.00 [34.00, 43.00] | 39.00 [35.50, 40.50] | -0.005 | >0.999 |
| Pre-intervention CO (L/min) | 6.12±1.23 | 6.15±1.10 | -0.083 | 0.934 |
| Pre-intervention CI | 3.26±0.30 | 3.40±0.29 | -1.95 | 0.055 |
| Pre-intervention CK-MB (U/L) | 103.37±6.27 | 103.55±8.47 | -0.107 | 0.915 |
| Pre-intervention cTnT (ng/mL) | 0.84±0.10 | 0.80±0.13 | 1.265 | 0.211 |
| Pre-intervention Hcy (μmol/L) | 19.80±3.73 | 18.52±3.67 | 1.501 | 0.138 |
Note: NYHA, New York Heart Function Classification; LVEDD, Left Ventricular End-Diastolic Diameter; LVEF, Left Ventricular Ejection Fraction; CO, Cardiac Output; CI, Cardiac Index; CK-MB, Creatine Kinase-MB; cTnT, Cardiac Troponin T; Hcy, Homocysteine; MLHFQ, Minnesota Cardiac Insufficiency Quality of Life Scale.